Pharma & Biotech

Eli Lilly and Company is entering 2026 with significant strategic and financial momentum, its shares trading at record highs on...

Healwell AI Inc. has entered 2026 navigating a complex landscape shaped by regulatory pressure and a fundamental strategic shift. The...

A notable upgrade from analysis platform Wall Street Zen has introduced a contrasting perspective on Organon & Co., setting it...

Shares of Capricor Therapeutics are undergoing a reassessment by market experts, reflecting a shift in sentiment. The biotech firm's stock,...

The investment thesis for pharmaceutical giant Novo Nordisk is undergoing a significant reassessment. While the company celebrates a key regulatory...

Entering the new year, BioNxt Solutions (BNXT) carries significant momentum, with investor focus shifting from near-term volatility to a clearly...

The new trading year has begun on a positive note for CureVac, with its shares posting significant gains. This upward...

Johnson & Johnson shares are trading near record highs, yet major institutional investors are sending mixed signals through their recent...

Redcare Pharmacy is entering 2026 under significant strain. The MDAX-listed company's shares have lost approximately half their value over the...

The telehealth provider Hims & Hers officially launched operations in Canada on December 4, 2025. This strategic move was executed...